Quotient Limited Provides an Update on Recent MosaiQ Milestone Achievements together with Third Quarter Fiscal 2020 Results
30 janv. 2020 06h00 HE
|
Quotient Limited
Molecular Disease Screening Microarray Feasibility Study CompletedInitial Serological Disease Screening FDA 510(k) Submission AcceptedCommencement of EU Expanded Immunohematology Field Trial...
Quotient Limited to Report Third Quarter 2020 Financial Results and Host Conference Call
21 janv. 2020 08h00 HE
|
Quotient Limited
JERSEY, Channel Islands, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter...
Quotient Limited Provides an Update on Recent Milestone Achievements for its MosaiQ Multimodality Multiplexing Diagnostic Platform
10 janv. 2020 16h05 HE
|
Quotient Limited
Initial Serological Disease Screening FDA 510k Submission ReceivedCommencement of EU Extended Immunohematology Field Trial Activities JERSEY, Channel Islands, Jan. 10, 2020 (GLOBE NEWSWIRE) --...
Quotient Announces Equity Awards
08 janv. 2020 08h00 HE
|
Quotient Limited
JERSEY, Channel Islands, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the planned appointment of Peter Buhler as Chief...
Quotient Announces Appointment of New Chief Financial Officer Peter Buhler and Chief Operating Officer Ed Farrell
07 janv. 2020 16h05 HE
|
Quotient Limited
Chris Lindop to Remain as Executive Vice President Reporting to Franz Walt CEO JERSEY, Channel Islands, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a...
Quotient Limited Reports Concordance Data from MDS Concept Study
05 déc. 2019 16h05 HE
|
Quotient Limited
JERSEY, Channel Islands, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported...
Quotient Limited to Participate in the Jefferies 2019 London Healthcare Conference
18 nov. 2019 09h00 HE
|
Quotient Limited
JERSEY, Channel Islands, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Executive Officer,...
Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares
12 nov. 2019 16h05 HE
|
Quotient Limited
JERSEY, Channel Islands, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the closing of its previously...
Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares
06 nov. 2019 22h00 HE
|
Quotient Limited
JERSEY, Channel Islands, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously...
Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
06 nov. 2019 16h20 HE
|
Quotient Limited
JERSEY, Channel Islands, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an...